Basics Genelux Corporation Common Stock IPO Date: January 26, 2023 Sector: Healthcare Industry: Biotech Market Cap: $95.85M Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 5.06% Avg Daily Range (30 D): $0.14 | 5.44% Avg Daily Range (90 D): $0.18 | 5.31% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .18M Trade Size Avg Trade Size (Sh.): 100 Avg Trade Size (Sh.) (30 D): 149 Avg Trade Size (Sh.) (90 D): 132 Institutional Trades Total Inst.Trades: 26 Avg Inst. Trade: $3.65M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.61M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 413.66K         News Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights May 24, 2024 @ 12:00 PM Genelux Corporation Announces Pricing of Approxima... Source: Genelux Corporation May 23, 2024 @ 8:01 PM Genelux Corporation Announces Proposed Public Offe... Source: Genelux Corporation Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.88 $-.21 $-.26 Diluted EPS $-.88 $-.21 $-.26 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -29.51M $ -7.49M $ -8.98M Operating Income / Loss $ -31.4M $ -7.82M $ -9.75M Cost of Revenue $ $ $ Net Cash Flow $ 12.15M $ 7.64M $ 2.46M PE Ratio